Announcements
- Equasens: 2023 Annual Results
- EQUASENS : Résultats Annuels 2023
- EQUASENS : BILAN SEMESTRIEL S2-2023 DU CONTRAT DE LIQUIDITE
- Equasens: 2023 revenue: €219.7m, +2.6%
- EQUASENS : Chiffre d’affaires 2023 : +2,6 % à 219,7 M€
- Equasens: Acquisition of a majority stake in DIGIPHARMACIE
- EQUASENS : Prise de participation majoritaire dans DIGIPHARMACIE
- Equasens: Changes in the Equasens Group Executive Committee
- EQUASENS : Evolution du Comité de Direction du Groupe Equasens
- EQUASENS: Acquisition of the German company ADV and creation of PHARMAGEST Germany
More ▼
Key statistics
On Tuesday, Equasens SA (0R9T:LSE) closed at 58.92, 26.71% above the 52 week low of 46.50 set on Feb 29, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | 58.92 |
Average volume | 1.94k |
---|---|
Shares outstanding | 15.17m |
Free float | 5.06m |
P/E (TTM) | 18.05 |
Market cap | 875.55m EUR |
EPS (TTM) | 3.20 EUR |
Annual div (ADY) | 1.15 EUR |
---|---|
Annual div yield (ADY) | 1.99% |
Div ex-date | Jul 03 2023 |
Div pay-date | Jul 05 2023 |
Data delayed at least 20 minutes, as of Apr 23 2024 17:26 BST.
More ▼